Evaluation of neural damage in Duchenne muscular dystrophy patients

The presence of non-progressive cognitive impairment is recognized as a common feature in a substantial proportion of patients with Duchenne muscular dystrophy (DMD). Concurrently, the amyloid beta peptide (Aβ(42)) protein has been associated with changes in memory and cognitive functions. Also, it...

Descripción completa

Detalles Bibliográficos
Autores principales: SALAM, EKRAM ABDEL, ABDEL-MEGUID, IMAN EHSAN, SHATLA, RANIA, KORRAA, SOHEIR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore SpA 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021626/
https://www.ncbi.nlm.nih.gov/pubmed/24843230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021626/
https://www.ncbi.nlm.nih.gov/pubmed/24843230

Ejemplares similares